Aethlon Medical, Inc.
AEMD · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $574 | $294 |
| % Growth | – | -100% | 95.2% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $574 | $294 |
| % Margin | – | – | 100% | 100% |
| R&D Expenses | $0 | $2,520 | $2,745 | $2,341 |
| G&A Expenses | $9,341 | $7,010 | $7,510 | $5,688 |
| SG&A Expenses | $9,341 | $12,637 | $12,473 | $10,715 |
| Sales & Mktg Exp. | $0 | $5,627 | $4,963 | $5,027 |
| Other Operating Expenses | $0 | -$2,520 | -$2,745 | -$2,341 |
| Operating Expenses | $9,341 | $12,637 | $12,473 | $10,715 |
| Operating Income | -$9,341 | -$12,637 | -$11,899 | -$10,421 |
| % Margin | – | – | -2,072% | -3,542.5% |
| Other Income/Exp. Net | -$4,047 | $428 | -$131 | $0 |
| Pre-Tax Income | -$13,388 | -$12,208 | -$12,030 | -$10,421 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$13,388 | -$12,208 | -$12,030 | -$10,416 |
| % Margin | – | – | -2,094.9% | -3,540.9% |
| EPS | -85.8 | -48.6 | -58.6 | -70.6 |
| % Growth | -76.5% | 17.1% | 17% | – |
| EPS Diluted | -85.8 | -48.6 | -58.6 | -70.6 |
| Weighted Avg Shares Out | 156 | 251 | 205 | 148 |
| Weighted Avg Shares Out Dil | 156 | 251 | 205 | 148 |
| Supplemental Information | – | – | – | – |
| Interest Income | $298 | $428 | $11 | $0 |
| Interest Expense | $10 | $0 | $0 | $0 |
| Depreciation & Amortization | $340 | $359 | $241 | $124 |
| EBITDA | -$13,038 | -$12,278 | -$11,658 | -$10,297 |
| % Margin | – | – | -2,030.1% | -3,500.5% |